TP53 and cancer: We also evaluated if the mutation-specific shRNAs are capable of silencing various mutants that occur at the same nucleotide position on p53. To test this hypothesis, we utilized the HEC-1A cancer cell line that expresses the R248Q mutation, and transfected the sh-4 which was initially generated against the R248W mutation.